Your browser doesn't support javascript.
loading
TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability.
Zhou, Sha; Peng, Jianhong; Xiao, Liuniu; Zhou, Caixia; Fang, Yujing; Ou, Qingjian; Qin, Jiayi; Liu, Mengzhong; Pan, Zhizhong; Hou, Zhenlin.
Afiliação
  • Zhou S; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Peng J; Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Xiao L; Department of Intensive Care Unit of Tongji Hospital, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Zhou C; Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Fang Y; Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Ou Q; Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Qin J; Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Liu M; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Pan Z; Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China. panzhzh@sysucc.org.cn.
  • Hou Z; Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China. houzl@sysucc.org.cn.
Cell Death Dis ; 12(5): 463, 2021 05 08.
Article em En | MEDLINE | ID: mdl-33966039
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Neoplasias Colorretais / Resistencia a Medicamentos Antineoplásicos / Ubiquitina-Proteína Ligases / Proteína Potenciadora do Homólogo 2 de Zeste / Proteínas com Motivo Tripartido / Oxaliplatina / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Neoplasias Colorretais / Resistencia a Medicamentos Antineoplásicos / Ubiquitina-Proteína Ligases / Proteína Potenciadora do Homólogo 2 de Zeste / Proteínas com Motivo Tripartido / Oxaliplatina / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Death Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China